TEST 1 - TERMS Flashcards
The abbreviation for the formal organization considered the leader in the classification of nursing diagnoses.
NANDA
An ongoing part of the nursing process and drug therapy, done consistently to monitor the client’s response to a drug.
EVALUATION
Initiation and completion of the nursing care plan occur during this phase.
IMPLEMENTATION
During this phase, subjective and objective data on the client, drug, or environment are collected.
ASSESSMENT
THIS is formulated when the nurse analyzes assessment information.
NURSING DIAGNOSIS
goals and outcome criteria are specified during this phase
PLANNING
An organizational framework for the practice of nursing.
NURSING PROCESS
Also known as the proprietary name of a drug
TRADE NAME
The length of time over which a drug concentration is sufficient to elicit a therapeutic response
DURATION
The time it takes for a drug to reach its maximum therapeutic response.
PEAK EFFECT
The time it takes for a drug to elicit a therapeutic response.
ONSET OF ACTION
A physiological or psychological need for a drug.
DEPENDENCE
A drug interaction that occurs when two drugs with similar actions are given together.
ADDITIVE
These drug effects result in structural defects in the fetus.
TERATOGENIC
These drug effects are permanent changes in the genetic composition of living organisms.
MUTAGENIC
These drug effects cause cancer.
CARCINOGENIC
Drug therapy used for the treatment of chronic illnesses.
MAINTENANCE THERAPY
Therapy that is used to make a client as comfortable as possible, and often used in the end stage of an illness.
PALLIATIVE
A genetically determined abnormal response to ordinary doses of a drug.
IDIOSYNCRATIC
The initial metabolism in the liver of a drug that is absorbed from the GI tract, before the drug reaches systemic circulation through the bloodstream.
FIRST-PASS EFFECT
Drugs that are available to consumers without a prescription.
OVER THE COUNTER
Canada’s federal legislation for publicly funded healthcare insurance.
CANADA HEALTH ACT
Application to the Therapeutic Products Directorate for a new drug.
NEW DRUG SUBMISSION
Allows drugs currently unavailable for sale to be made available under special conditions.
SPECIAL ACCESS
Placed on the label of prescription and over-the-counter drug products that have been evaluated and approved for sale by the Therapeutic Products Directorate.
DRUG IDENTIFICATION NUMBER
Required prior to selling a product by prescription to ensure that the drug and manufacturing process are safe and effective.
NOTICE OF COMPLIANCE
An inactive or inert substance that may be used in experimental studies.
PLACEBO
Allows pharmaceutical companies intellectual property rights and a time frame during which drugs can be marketed without competition from generic drugs.
PATENT ACT
A drug not approved for marketing by Health Canada but available for use in studies to determine its safety and efficacy.
INVESTIGATIONAL NEW DRUG